AU2002352524B2
(en)
*
|
2001-11-07 |
2007-10-04 |
Nektar Therapeutics |
Branched polymers and their conjugates
|
ATE412684T1
(de)
*
|
2002-09-09 |
2008-11-15 |
Nektar Therapeutics Al Corp |
Verfahren zur herstellung von wasserlöslichen polymerderivaten mit terminalen carboxylgruppen
|
EA200500475A1
(ru)
|
2002-09-09 |
2005-10-27 |
Нектар Терапеутикс Ал, Корпорейшн |
Водорастворимые полимерные алканалы
|
EP1591467A1
(en)
*
|
2002-09-09 |
2005-11-02 |
Nektar Therapeutics Al, Corporation |
Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone
|
US7462687B2
(en)
|
2002-11-12 |
2008-12-09 |
Enzon Pharmaceuticals, Inc. |
Prodrugs of vancomycin with hydrolysis resistant polymer linkages
|
AU2003287605A1
(en)
|
2002-11-12 |
2004-06-03 |
Enzon Pharmaceuticals, Inc. |
Polymeric prodrugs of vancomycin
|
GB0301014D0
(en)
*
|
2003-01-16 |
2003-02-19 |
Biocompatibles Ltd |
Conjugation reactions
|
DK2163643T3
(en)
*
|
2003-03-05 |
2015-03-23 |
Halozyme Inc |
Soluble hyaluronidaseglycoprotein (sHASEGP), process for preparing the same, pharmaceutical compositions and uses thereof covered
|
US20090123367A1
(en)
*
|
2003-03-05 |
2009-05-14 |
Delfmems |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
|
US7871607B2
(en)
*
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
US20060104968A1
(en)
*
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
US20040249119A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Fox Martin Edward |
Novel mPEG propionaldehyde precursor
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
JP2007501812A
(ja)
*
|
2003-08-08 |
2007-02-01 |
ノボ ノルディスク アクティーゼルスカブ |
ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用
|
SG176455A1
(en)
*
|
2003-10-09 |
2011-12-29 |
Ambrx Inc |
Polymer derivatives
|
US7754500B2
(en)
*
|
2003-11-21 |
2010-07-13 |
Anp Technologies, Inc. |
Asymmetrically branched polymer conjugates and microarray assays
|
AU2005209926B2
(en)
*
|
2004-02-02 |
2007-09-06 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
WO2005108463A2
(en)
|
2004-05-03 |
2005-11-17 |
Nektar Therapeutics Al, Corporation |
Branched polyethylen glycol derivates comprising an acetal or ketal branching point
|
EP1771205B1
(en)
*
|
2004-06-18 |
2016-10-26 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
KR101100059B1
(ko)
|
2004-06-30 |
2011-12-29 |
넥타르 테라퓨틱스 |
중합체인자 ix 부분의 접합체
|
EP2359842A1
(en)
|
2004-07-14 |
2011-08-24 |
University of Utah Research Foundation |
Netrin-related compositions and uses
|
ES2355642T3
(es)
*
|
2004-07-16 |
2011-03-29 |
Nektar Therapeutics |
Conjugados que comprenden una porcion de gm-csf y un polimero.
|
AU2005327906B2
(en)
*
|
2004-07-21 |
2010-05-13 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
EP1807436B1
(en)
*
|
2004-10-25 |
2014-06-18 |
Intezyne Technologies Inc. |
Heterobifunctional poly(ethylene glycol) and uses thereof
|
MX2007007591A
(es)
|
2004-12-22 |
2007-07-25 |
Ambrx Inc |
Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
|
ATE541934T1
(de)
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
EP2284191A3
(en)
|
2004-12-22 |
2011-07-20 |
Ambrx, Inc. |
Process for the preparation of hGH
|
US7638491B2
(en)
|
2004-12-22 |
2009-12-29 |
Ambrx, Inc. |
Therapies using non-natural amino acids and polypeptides
|
NZ555386A
(en)
*
|
2004-12-22 |
2011-01-28 |
Ambrx Inc |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
CN101163506B
(zh)
|
2004-12-27 |
2012-09-26 |
巴克斯特国际公司 |
聚合物-von Willebrand因子偶联物
|
WO2006094530A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
WO2006102484A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Anp Technologies, Inc. |
Symmetrically branched polymer conjugates and microarray assays
|
US20060233740A1
(en)
*
|
2005-03-23 |
2006-10-19 |
Bossard Mary J |
Conjugates of an hGH moiety and a polymer
|
DE602006019709D1
(US20030143596A1-20030731-C00011.png)
|
2005-05-02 |
2011-03-03 |
Anp Technologies Inc |
|
CA2609205A1
(en)
|
2005-06-03 |
2006-12-14 |
Ambrx, Inc. |
Improved human interferon molecules and their uses
|
WO2007011802A1
(en)
*
|
2005-07-18 |
2007-01-25 |
Nektar Therapeutics Al, Corporation |
Method for preparing branched functionalized polymers using branched polyol cores
|
JP2007112924A
(ja)
*
|
2005-10-21 |
2007-05-10 |
National Institute For Materials Science |
高分子架橋剤及びこの架橋剤を用いたリポソーム又は細胞の架橋体
|
WO2007059312A2
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
CU23556A1
(es)
*
|
2005-11-30 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico
|
EP1960447A4
(en)
|
2005-12-08 |
2010-12-01 |
Tyco Healthcare |
BIOCOMPATIBLE SURGICAL COMPOSITIONS
|
AU2006326404B2
(en)
*
|
2005-12-14 |
2011-11-03 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
EP1968644B1
(en)
*
|
2005-12-16 |
2012-06-27 |
Nektar Therapeutics |
Polymer conjugates of glp-1
|
US20100012883A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Functional Polymeric Phase Change Materials
|
US20070173154A1
(en)
*
|
2006-01-26 |
2007-07-26 |
Outlast Technologies, Inc. |
Coated articles formed of microcapsules with reactive functional groups
|
US20100016513A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Functional Polymeric Phase Change Materials and Methods of Manufacturing the Same
|
US8404341B2
(en)
|
2006-01-26 |
2013-03-26 |
Outlast Technologies, LLC |
Microcapsules and other containment structures for articles incorporating functional polymeric phase change materials
|
US9234059B2
(en)
*
|
2008-07-16 |
2016-01-12 |
Outlast Technologies, LLC |
Articles containing functional polymeric phase change materials and methods of manufacturing the same
|
US20100166700A1
(en)
*
|
2006-02-28 |
2010-07-01 |
Oligasis Corporation |
Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation
|
EP1834963A1
(en)
*
|
2006-03-13 |
2007-09-19 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
AU2007245190B2
(en)
*
|
2006-03-31 |
2011-07-21 |
Takeda Pharmaceutical Company Limited |
Pegylated factor VIII
|
US7982010B2
(en)
*
|
2006-03-31 |
2011-07-19 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
US7985839B2
(en)
*
|
2006-03-31 |
2011-07-26 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
US7560588B2
(en)
|
2006-04-27 |
2009-07-14 |
Intezyne Technologies, Inc. |
Poly(ethylene glycol) containing chemically disparate endgroups
|
EP2018437A2
(en)
*
|
2006-05-02 |
2009-01-28 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
WO2008019217A2
(en)
|
2006-07-17 |
2008-02-14 |
The Research Foundation Of State University Of New York |
Stereoregular romp polymers
|
WO2008030613A2
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Hybrid suppressor trna for vertebrate cells
|
AU2007292903B2
(en)
|
2006-09-08 |
2012-03-29 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
US8367065B2
(en)
*
|
2006-09-15 |
2013-02-05 |
Enzon Pharmaceuticals, Inc. |
Targeted polymeric prodrugs containing multifunctional linkers
|
CA2662973A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Enzon Pharmaceuticals, Inc. |
Lysine-based polymeric linkers
|
CN101557830B
(zh)
|
2006-12-15 |
2016-06-08 |
巴克斯特国际公司 |
具有延长的体内半衰期的因子VIIa-聚唾液酸结合物
|
US20140011964A1
(en)
*
|
2007-02-28 |
2014-01-09 |
Serina Therapeutics, Inc. |
Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
|
BRPI0809583B1
(pt)
|
2007-03-30 |
2022-02-22 |
Ambrx, Inc |
Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo
|
WO2008137471A2
(en)
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
CA2707840A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
US20100203066A1
(en)
*
|
2007-08-20 |
2010-08-12 |
Enzon Pharmaceuticals, Inc. |
Polymeric linkers containing pyridyl disulfide moieties
|
US8946148B2
(en)
|
2007-11-20 |
2015-02-03 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
US9345809B2
(en)
|
2007-11-28 |
2016-05-24 |
Fziomed, Inc. |
Carboxymethylcellulose polyethylene glycol compositions for medical uses
|
CN101939443B
(zh)
|
2008-02-08 |
2014-01-29 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
ES2453946T3
(es)
*
|
2008-04-03 |
2014-04-09 |
Biosteed Gene Expression Tech. Co., Ltd. |
Hormona del crecimiento modificada con polietilenglicol bicatenario, método de preparación y aplicación de esta
|
KR20100135291A
(ko)
|
2008-04-14 |
2010-12-24 |
할로자임, 아이엔씨 |
히알루로난 관련 질환 및 상태 치료용 변형된 히알루로니다제 및 그 용도
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
US8476404B1
(en)
*
|
2008-07-04 |
2013-07-02 |
Bhalchandra Shripad Lele |
Selectively functionalized polyhydric compounds
|
US20100015430A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Heat Regulating Article With Moisture Enhanced Temperature Control
|
US8221910B2
(en)
|
2008-07-16 |
2012-07-17 |
Outlast Technologies, LLC |
Thermal regulating building materials and other construction components containing polymeric phase change materials
|
UA118536C2
(uk)
|
2008-07-23 |
2019-02-11 |
Амбркс, Інк. |
Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
|
AU2009282413B2
(en)
|
2008-08-11 |
2014-07-17 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
WO2010033220A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
WO2010033215A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of aod-like peptides
|
WO2010033222A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Netkar Therapeutics |
Polymer conjugates of ziconotide peptides
|
EP2340047A1
(en)
*
|
2008-09-19 |
2011-07-06 |
Nektar Therapeutics |
Polymer conjugates of kiss1 peptides
|
WO2010042145A1
(en)
*
|
2008-09-19 |
2010-04-15 |
Nektar Therapeutics |
Polymer conjugates of glp-2-like peptides
|
EP2334338A2
(en)
*
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of c-peptides
|
EP2340045B1
(en)
|
2008-09-19 |
2017-04-12 |
Nektar Therapeutics |
Polymer conjugates of protegrin peptides
|
EP2334335A1
(en)
*
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of cd-np peptides
|
US20110165113A1
(en)
*
|
2008-09-19 |
2011-07-07 |
Nektar Therapeutics |
Polymer conjugates of v681-like peptides
|
US20110171165A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of opioid growth factor peptides
|
US8680263B2
(en)
*
|
2008-09-19 |
2014-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
WO2010033218A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of osteocalcin peptides
|
WO2010033227A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of thymosin alpha 1 peptides
|
ES2660000T3
(es)
|
2008-09-26 |
2018-03-20 |
Ambrx, Inc. |
Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
|
BRPI0919403A2
(pt)
|
2008-09-26 |
2017-09-26 |
Ambrx Inc |
polipeptídeos modificados de eritropoetina animal e seus usos
|
WO2010045321A2
(en)
*
|
2008-10-15 |
2010-04-22 |
Baxter International Inc. |
Pegylation of recombinant blood coagulation factors in the presence of bound antibodies
|
PT3037529T
(pt)
|
2008-12-09 |
2019-05-31 |
Halozyme Inc |
Polipéptidos ph20 estendidos solúveis e suas utilizações
|
CN101870728A
(zh)
|
2009-04-23 |
2010-10-27 |
派格生物医药(苏州)有限公司 |
新型Exendin变体及其缀合物
|
TW201042257A
(en)
*
|
2009-05-26 |
2010-12-01 |
Baxter Int |
Detection of antibody that binds to water soluble polymer-modified polypeptides
|
RU2533619C2
(ru)
|
2009-07-27 |
2014-11-20 |
Лайпоксен Текнолоджиз Лимитед |
Гликополисиалирование белков, не являющихся белками свертывания крови
|
US8642737B2
(en)
|
2010-07-26 |
2014-02-04 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
US8809501B2
(en)
|
2009-07-27 |
2014-08-19 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
KR101832937B1
(ko)
*
|
2009-07-27 |
2018-02-28 |
박스알타 인코퍼레이티드 |
혈액 응고 단백질 복합체
|
HUE028056T2
(en)
|
2009-07-27 |
2016-11-28 |
Baxalta GmbH |
Blood coagulation protein conjugates
|
WO2011034604A2
(en)
|
2009-09-17 |
2011-03-24 |
Baxter Healthcare, S.A. |
Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
US8697648B2
(en)
*
|
2009-10-20 |
2014-04-15 |
Georgia State University Research Foundation, Inc. |
Protein agent for diabetes treatment and β cell imaging
|
WO2011081915A2
(en)
*
|
2009-12-15 |
2011-07-07 |
Cebix Inc. |
Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
WO2011087808A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
MX2012006980A
(es)
|
2009-12-21 |
2012-07-17 |
Ambrx Inc |
Polipeptidos de somatotropina porcina modificados y sus usos.
|
EP2536753B1
(en)
*
|
2010-02-16 |
2017-12-20 |
Novo Nordisk A/S |
Factor viii molecules with reduced vwf binding
|
CN103119055A
(zh)
*
|
2010-05-17 |
2013-05-22 |
塞比克斯公司 |
聚乙二醇化c肽
|
JP5825507B2
(ja)
*
|
2010-06-25 |
2015-12-02 |
日油株式会社 |
分岐型ヘテロポリエチレングリコール
|
US10040761B2
(en)
*
|
2010-06-25 |
2018-08-07 |
Nof Corporation |
Branched hetero polyethylene glycol and intermediate
|
MX348420B
(es)
|
2010-07-20 |
2017-06-12 |
Halozyme Inc |
Efectos secundarios adversos asociados con la administracion de agentes anti-hialuronano y metodos para mejorar o prevenir los efectos secundarios.
|
EP4023247A1
(en)
|
2010-07-30 |
2022-07-06 |
Takeda Pharmaceutical Company Limited |
Nucleophilic catalysts for oxime linkage
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
BR112013003522B1
(pt)
|
2010-08-17 |
2021-05-25 |
Ambrx, Inc. |
polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira
|
US8841382B2
(en)
|
2010-09-01 |
2014-09-23 |
Basf Se |
Hyperbranched polyethers/dendrimers for solubilzation of sparingly soluble active ingredients
|
EP2611847B1
(de)
*
|
2010-09-01 |
2018-11-07 |
Basf Se |
Amphiphil zur solubilisierung schwerlöslicher wirkstoffe
|
JP6042335B2
(ja)
*
|
2010-09-15 |
2016-12-14 |
ノヴォ ノルディスク アー/エス |
細胞取込みが低下した第viii因子変異体
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
WO2012054822A1
(en)
|
2010-10-22 |
2012-04-26 |
Nektar Therapeutics |
Pharmacologically active polymer-glp-1 conjugates
|
US20140371258A1
(en)
|
2010-12-17 |
2014-12-18 |
Nektar Therapeutics |
Water-Soluble Polymer Conjugates of Topotecan
|
JP5899241B2
(ja)
|
2010-12-21 |
2016-04-06 |
ネクター セラピューティクス |
ペメトレキセドベースの化合物のマルチアームポリマープロドラッグコンジュゲート
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
HUE049352T2
(hu)
|
2010-12-22 |
2020-09-28 |
Baxalta GmbH |
Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
EP2654797B1
(en)
|
2010-12-23 |
2017-11-08 |
Nektar Therapeutics |
Polymer-des-ethyl sunitinib conjugates
|
WO2012088506A1
(en)
|
2010-12-23 |
2012-06-28 |
Nektar Therapeutics |
Polymer-semaxanib moiety conjugates
|
US9827326B2
(en)
|
2010-12-23 |
2017-11-28 |
Nektar Therapeutics |
Polymer-sunitinib conjugates
|
EP2672958A1
(en)
|
2011-02-08 |
2013-12-18 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
US8673448B2
(en)
|
2011-03-04 |
2014-03-18 |
Outlast Technologies Llc |
Articles containing precisely branched functional polymeric phase change materials
|
MX343093B
(es)
|
2011-04-06 |
2016-10-25 |
Stepan Co |
Polimeros de uretano hidrofilos, de multiples brazos, metodos para prepararlos, y composiciones y procesos que los emplean.
|
US20120329127A1
(en)
|
2011-05-27 |
2012-12-27 |
Baxter Healthcare S.A. |
Therapeutic proteins with increased half-life and methods of preparing same
|
WO2012166555A1
(en)
|
2011-05-27 |
2012-12-06 |
Nektar Therapeutics |
Water - soluble polymer - linked binding moiety and drug compounds
|
BR112013032265A2
(pt)
|
2011-06-17 |
2016-12-20 |
Halozyme Inc |
métodos de infusão de insulina subcutânea contínua com uma enzima de degradação do hialuronano
|
US20130011378A1
(en)
|
2011-06-17 |
2013-01-10 |
Tzung-Horng Yang |
Stable formulations of a hyaluronan-degrading enzyme
|
US20130071394A1
(en)
|
2011-09-16 |
2013-03-21 |
John K. Troyer |
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
|
SG11201401797TA
(en)
|
2011-10-24 |
2014-09-26 |
Halozyme Inc |
Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
|
WO2013075117A2
(en)
|
2011-11-17 |
2013-05-23 |
John Wahren |
Pegylated c-peptide
|
LT3130347T
(lt)
|
2011-12-30 |
2019-10-25 |
Halozyme Inc |
Ph20 polipeptido variantai, kompozicijos ir jų panaudojimas
|
ES2661575T3
(es)
|
2012-03-30 |
2018-04-02 |
The Board Of Regents Of The University Of Oklahoma |
Producción de polímeros de heparosano de peso molecular alto y métodos de producción y uso de los mismos
|
JP6042527B2
(ja)
|
2012-04-04 |
2016-12-14 |
ハロザイム インコーポレイテッド |
抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療
|
AU2013204754C1
(en)
|
2012-05-16 |
2018-10-11 |
Takeda Pharmaceutical Company Limited |
Nucleophilic Catalysts for Oxime Linkage
|
EP2859017B1
(en)
|
2012-06-08 |
2019-02-20 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
ES2611788T3
(es)
|
2012-06-26 |
2017-05-10 |
Sutro Biopharma, Inc. |
Proteínas de Fc modificadas que comprenden residuos de aminoácidos no naturales específicos del sitio, conjugados de las mismas, métodos para su preparación y métodos para su uso
|
SG11201501464TA
(en)
|
2012-08-31 |
2015-03-30 |
Sutro Biopharma Inc |
Modified amino acids comprising an azido group
|
US9278124B2
(en)
|
2012-10-16 |
2016-03-08 |
Halozyme, Inc. |
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
|
EP2947111B1
(en)
*
|
2013-01-17 |
2018-03-07 |
Xiamen Sinopeg Biotech Co., Ltd. |
Monofunctional branched polyethyleneglycol and bio-related substance modified by same
|
CN104936626B
(zh)
|
2013-02-04 |
2018-08-03 |
W.L.戈尔及同仁股份有限公司 |
用于基材的涂层
|
US9272075B2
(en)
|
2013-02-04 |
2016-03-01 |
W.L. Gore & Associates, Inc. |
Coating for substrate
|
TW201534726A
(zh)
|
2013-07-03 |
2015-09-16 |
Halozyme Inc |
熱穩定ph20玻尿酸酶變異體及其用途
|
US9764039B2
(en)
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
US10702608B2
(en)
|
2013-09-08 |
2020-07-07 |
Kodiak Sciences Inc. |
Factor VIII zwitterionic polymer conjugates
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
SG10201806917PA
(en)
|
2013-10-15 |
2018-09-27 |
Seattle Genetics Inc |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
EP3092263B1
(en)
*
|
2014-01-10 |
2018-02-21 |
ETH Zurich |
Polyethylene glycol substituted acyl borates
|
JP6106103B2
(ja)
|
2014-01-16 |
2017-03-29 |
信越化学工業株式会社 |
末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法、並びにこれに用いる新規なアセタール基含有アルコール化合物及びそのアルカリ金属塩
|
JP6106104B2
(ja)
|
2014-01-16 |
2017-03-29 |
信越化学工業株式会社 |
末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
CN104109238A
(zh)
*
|
2014-07-13 |
2014-10-22 |
成都市绿科华通科技有限公司 |
六方孔状功能聚乙二醇的制备方法
|
PL3186281T3
(pl)
|
2014-08-28 |
2019-10-31 |
Halozyme Inc |
Terapia skojarzona enzymem rozkładającym hialuronian i inhibitorem punktu kontrolnego odpowiedzi immunologicznej
|
EA201700181A1
(ru)
|
2014-10-14 |
2017-09-29 |
Галозим, Инк. |
Композиции аденозиндеаминазы-2 (ада-2), их варианты и способы использования
|
KR101585795B1
(ko)
*
|
2014-10-14 |
2016-01-15 |
주식회사 파이토켐텍 |
활성 성분으로 디에칠렌글라이콜모노벤질에텔을 함유하는 보존제 조성물
|
KR20210013299A
(ko)
|
2014-10-17 |
2021-02-03 |
코디악 사이언시스 인코포레이티드 |
부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
|
US9434778B2
(en)
|
2014-10-24 |
2016-09-06 |
Bristol-Myers Squibb Company |
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
|
EP3221334B1
(en)
|
2014-11-19 |
2020-02-19 |
Nzp Uk Limited |
6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
|
EP3221333B1
(en)
|
2014-11-19 |
2019-07-24 |
NZP UK Limited |
6.alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal fxr modulators
|
BR112017010319B1
(pt)
|
2014-11-19 |
2023-04-11 |
NZP UK Limited |
Esteroides 6-alquil-7-hidróxi-4-en-3-ona e processo para a preparação dos mesmos
|
KR102526632B1
(ko)
|
2014-11-19 |
2023-04-27 |
엔제트피 유케이 리미티드 |
스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
|
US10003053B2
(en)
|
2015-02-04 |
2018-06-19 |
Global Web Horizons, Llc |
Systems, structures and materials for electrochemical device thermal management
|
US10431858B2
(en)
|
2015-02-04 |
2019-10-01 |
Global Web Horizons, Llc |
Systems, structures and materials for electrochemical device thermal management
|
US10120948B2
(en)
|
2015-10-13 |
2018-11-06 |
Google Llc |
Providing notifications based on geofencing search results
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
JP2019501131A
(ja)
|
2015-12-04 |
2019-01-17 |
シアトル ジェネティックス, インコーポレイテッド |
四級化チューブリシン化合物の複合体
|
CN106905120B
(zh)
*
|
2015-12-21 |
2020-04-28 |
北京键凯科技股份有限公司 |
Y型多缩乙二醇衍生物及其制备方法
|
BR112018013407A2
(pt)
|
2015-12-30 |
2018-12-18 |
Kodiak Sciences Inc |
anticorpos e conjugados dos mesmos
|
US11708413B2
(en)
|
2016-01-27 |
2023-07-25 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
SG11201807827VA
(en)
|
2016-03-25 |
2018-10-30 |
Seattle Genetics Inc |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
GB201608777D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Compounds
|
GB201608776D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|
WO2018066692A1
(ja)
*
|
2016-10-07 |
2018-04-12 |
国立大学法人東京工業大学 |
分岐型ヘテロ単分散ポリエチレングリコール、その製造方法、及びその結合体
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
TW201837051A
(zh)
|
2017-02-08 |
2018-10-16 |
美商必治妥美雅史谷比公司 |
包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
|
AU2018237683A1
(en)
|
2017-03-24 |
2019-10-31 |
Seagen Inc. |
Process for the preparation of glucuronide drug-linkers and intermediates thereof
|
SG10202110492YA
(en)
|
2017-06-22 |
2021-11-29 |
Catalyst Biosciences Inc |
Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
|
EP3652316A4
(en)
|
2017-07-11 |
2021-04-07 |
Synthorx, Inc. |
INTEGRATION OF NON-NATURAL NUCLEOTIDES AND METHOD FOR THEREFORE
|
US11622993B2
(en)
|
2017-08-03 |
2023-04-11 |
Synthorx, Inc. |
Cytokine conjugates for the treatment of autoimmune diseases
|
JP7423513B2
(ja)
|
2017-09-18 |
2024-01-29 |
ストロ バイオファーマ インコーポレーテッド |
抗葉酸受容体α抗体コンジュゲート及びその使用
|
US20190351031A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
AU2019337610A1
(en)
|
2018-09-11 |
2021-05-06 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
EP3852811A1
(en)
|
2018-09-17 |
2021-07-28 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
CN110964116A
(zh)
|
2018-09-26 |
2020-04-07 |
北京辅仁瑞辉生物医药研究院有限公司 |
GLP1-Fc融合蛋白及其缀合物
|
EP3867265A1
(en)
|
2018-10-19 |
2021-08-25 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
|
CN113661239A
(zh)
|
2018-12-28 |
2021-11-16 |
催化剂生物科学公司 |
经修饰的尿激酶型纤溶酶原激活物多肽和使用方法
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
CN113660946A
(zh)
|
2019-02-06 |
2021-11-16 |
新索思股份有限公司 |
Il-2缀合物及其使用方法
|
WO2020168017A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
US20220362394A1
(en)
|
2019-05-03 |
2022-11-17 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
JP2022536490A
(ja)
|
2019-06-10 |
2022-08-17 |
ストロ バイオファーマ インコーポレーテッド |
5H-ピロロ[3,2-d]ピリミジン-2,4-ジアミノ化合物およびその抗体コンジュゲート
|
CN114746420A
(zh)
|
2019-06-17 |
2022-07-12 |
苏特罗生物制药公司 |
用于癌症治疗和诊断的作为Toll样受体(TLR)7/8激动剂的1-(4-(氨基甲基)苄基)-2-丁基-2H-吡唑并[3,4-c]喹啉-4-胺衍生物及相关化合物以及其抗体药物偶联物
|
CN112175088B
(zh)
|
2019-07-02 |
2023-03-28 |
江苏晟斯生物制药有限公司 |
改进的fix融合蛋白、缀合物及其应用
|
KR20220061158A
(ko)
|
2019-09-10 |
2022-05-12 |
신톡스, 인크. |
자가면역질환을 치료하기 위한 il-2 접합체 및 사용 방법
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
MX2022005251A
(es)
|
2019-11-04 |
2022-06-08 |
Synthorx Inc |
Conjugados de interleuquina 10 y sus usos.
|
EP4114852A1
(en)
|
2020-03-03 |
2023-01-11 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
CA3174114A1
(en)
|
2020-03-11 |
2021-09-16 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
CA3128035A1
(en)
|
2020-08-13 |
2022-02-13 |
Bioasis Technologies, Inc. |
Combination therapies for delivery across the blood brain barrier
|
US20230302150A1
(en)
|
2020-08-20 |
2023-09-28 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
TW202228784A
(zh)
|
2020-09-23 |
2022-08-01 |
奧地利商艾柏力維亞生技有限公司 |
用以於一患者中螯合非預期的抗peg抗體的化合物
|
WO2022103983A2
(en)
|
2020-11-11 |
2022-05-19 |
Sutro Biopharma, Inc. |
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
|
IL307282A
(en)
|
2021-04-03 |
2023-11-01 |
Ambrx Inc |
Antidote conjugates against HER2 and their applications
|
EP4329818A1
(en)
|
2021-04-30 |
2024-03-06 |
Celgene Corporation |
Combination therapies using an anti-bcma antibody drug conjugate (adc) in combination with a gamma secretase inhibitor (gsi)
|
WO2024006272A1
(en)
|
2022-06-27 |
2024-01-04 |
Sutro Biopharma, Inc. |
β-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF
|
US20240058465A1
(en)
|
2022-06-30 |
2024-02-22 |
Sutro Biopharma, Inc. |
Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates
|
WO2024015229A1
(en)
|
2022-07-15 |
2024-01-18 |
Sutro Biopharma, Inc. |
Protease/enzyme cleavable linker-payloads and protein conjugates
|
WO2024044780A1
(en)
|
2022-08-26 |
2024-02-29 |
Sutro Biopharma, Inc. |
Interleukin-18 variants and uses thereof
|
CN115873231A
(zh)
*
|
2022-12-17 |
2023-03-31 |
华南理工大学 |
一种聚乙二醇修饰的氨基糖苷类分子及其制备方法和应用
|